Literature DB >> 15355564

Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank.

Raj P Kapur1, Zhenqiang Yao, Malissa H K Iida, Christine M Clarke, Barbara Doggett, Lianping Xing, Brendan F Boyce.   

Abstract

UNLABELLED: We report the first case of lethal autosomal recessive osteopetrosis in mice caused by a spontaneous 8-bp deletion in exon 2 of the Rank gene. The phenotype, including a block in RANKL-dependent osteoclast differentiation and lymph node agenesis, copies that of Rank(-/-) mice, which have been produced by targeted recombination.
INTRODUCTION: Commitment of osteoclast progenitors to the osteoclast lineage requires RANKL/RANK-mediated intercellular signals. Gene-targeted defects in this signaling pathway resulted in osteoclast deficiency and severe osteopetrosis in mice, but to date, there have been no reports of spontaneous mutations in Rankl or Rank resulting in osteopetrosis.
MATERIALS AND METHODS: Mice with malignant osteopetrosis and absent lymph nodes appeared spontaneously in a highly inbred colony. Appropriate crosses were analyzed to establish the pattern of inheritance. Tissues from affected pups and littermates were evaluated grossly, histopathologically, and radiographically. Osteoclast development from splenocytes was tested in vitro under a variety of conditions, including after infection with RANK-encoding retrovirus. Rank mutational analysis was performed by direct sequencing of RT-PCR products and genomic DNA.
RESULTS: The inheritance pattern was consistent with autosomal recessive inheritance, and the phenotype resembled that of either Rankl or Rank knockout mice with the exception of as yet unexplained death of most mice 2-3 weeks after weaning. Osteoclast precursors from the spleens of affected pups failed to form osteoclasts in vitro when stimulated with macrophage-colony stimulating factor (M-CSF) and RANKL, unless they were forced to express wildtype Rank cDNA. Molecular genetic studies identified an 8-bp deletion in exon 2 of the Rank gene. The resulting allele, termed Rank(del8), encodes only a small portion of the RANK extracellular domain, which is probably nonfunctional.
CONCLUSIONS: The phenotypic similarities between Rank(del8) and mice previously described with a combined insertion and deletion in Rank confirm the role of this receptor in osteoclastogenesis and lymph node development and suggest that some forms of malignant osteopetrosis in humans could result from a similar defect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355564     DOI: 10.1359/JBMR.040713

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  12 in total

1.  The RANKL/RANK/OPG pathway.

Authors:  Brendan F Boyce; Lianping Xing
Journal:  Curr Osteoporos Rep       Date:  2007-09       Impact factor: 5.096

Review 2.  Functions of RANKL/RANK/OPG in bone modeling and remodeling.

Authors:  Brendan F Boyce; Lianping Xing
Journal:  Arch Biochem Biophys       Date:  2008-03-25       Impact factor: 4.013

Review 3.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

4.  Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Chunlin Qin; Edward M Schwarz; Brendan F Boyce
Journal:  J Biol Chem       Date:  2008-02-04       Impact factor: 5.157

5.  Toward improved phosphorus efficiency in monogastrics-interplay of serum, minerals, bone, and immune system after divergent dietary phosphorus supply in swine.

Authors:  Michael Oster; Franziska Just; Kirsten Büsing; Petra Wolf; Christian Polley; Brigitte Vollmar; Eduard Muráni; Siriluck Ponsuksili; Klaus Wimmers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-09       Impact factor: 3.619

6.  The First Scube3 Mutant Mouse Line with Pleiotropic Phenotypic Alterations.

Authors:  Helmut Fuchs; Sibylle Sabrautzki; Gerhard K H Przemeck; Stefanie Leuchtenberger; Bettina Lorenz-Depiereux; Lore Becker; Birgit Rathkolb; Marion Horsch; Lillian Garrett; Manuela A Östereicher; Wolfgang Hans; Koichiro Abe; Nobuho Sagawa; Jan Rozman; Ingrid L Vargas-Panesso; Michael Sandholzer; Thomas S Lisse; Thure Adler; Juan Antonio Aguilar-Pimentel; Julia Calzada-Wack; Nicole Ehrhard; Ralf Elvert; Christine Gau; Sabine M Hölter; Katja Micklich; Kristin Moreth; Cornelia Prehn; Oliver Puk; Ildiko Racz; Claudia Stoeger; Alexandra Vernaleken; Dian Michel; Susanne Diener; Thomas Wieland; Jerzy Adamski; Raffi Bekeredjian; Dirk H Busch; John Favor; Jochen Graw; Martin Klingenspor; Christoph Lengger; Holger Maier; Frauke Neff; Markus Ollert; Tobias Stoeger; Ali Önder Yildirim; Tim M Strom; Andreas Zimmer; Eckhard Wolf; Wolfgang Wurst; Thomas Klopstock; Johannes Beckers; Valerie Gailus-Durner; Martin Hrabé de Angelis
Journal:  G3 (Bethesda)       Date:  2016-12-07       Impact factor: 3.154

7.  TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis.

Authors:  Jinbo Li; Akram Ayoub; Yan Xiu; Xiaoxiang Yin; James O Sanders; Addisu Mesfin; Lianping Xing; Zhenqiang Yao; Brendan F Boyce
Journal:  Nat Commun       Date:  2019-06-26       Impact factor: 14.919

8.  RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations.

Authors:  Alessandra Pangrazio; Barbara Cassani; Matteo M Guerrini; Julie C Crockett; Veronica Marrella; Luca Zammataro; Dario Strina; Ansgar Schulz; Claire Schlack; Uwe Kornak; David J Mellis; Angela Duthie; Miep H Helfrich; Anne Durandy; Despina Moshous; Ashok Vellodi; Robert Chiesa; Paul Veys; Nadia Lo Iacono; Paolo Vezzoni; Alain Fischer; Anna Villa; Cristina Sobacchi
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

Review 9.  Biology of RANK, RANKL, and osteoprotegerin.

Authors:  Brendan F Boyce; Lianping Xing
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 10.  RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease.

Authors:  Nadia Lo Iacono; Alessandra Pangrazio; Mario Abinun; Robbert Bredius; Marco Zecca; Harry C Blair; Paolo Vezzoni; Anna Villa; Cristina Sobacchi
Journal:  Clin Dev Immunol       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.